Protagonist Therapeutics eyes a Johnson & Johnson buyout interest, with blockbuster drug potential and high acquisition hopes ...

Stocks rebounded Wednesday, with the S&P 500 and Nasdaq setting fresh intraday and closing records, while gold futures ...